Skip to main content

Advertisement

Table 5 Life expectancy estimates at age 20 years, showing unadjusted and adjusted values (assuming 30 % mortality among those lost to follow-up), n = 9997

From: Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada

  Unadjusted Adjusted
eOx (SE) eOx (SE)
Overall 45.2 (0.66) 37.5 (0.61)
Sex   
Female 40.1 (1.34) 32.4 (1.12)
Male 47.0 (0.75) 39.2 (0.72)
History of IDU   
Yes 28.2 (1.07) 23.9 (0.96)
No 63.9 (0.92) 52.3 (0.84)
Aboriginal ancestry   
Yes 19.1 (1.60) 17.7 (1.49)
No 62.7 (1.12) 51.2 (0.97)
Baseline CD4 (cells/μL)   
<350 44.1 (0.77) 36.3 (0.70)
≥350 50.8 (1.35) 43.5 (1.25)
Year of ART initiation   
2000–2003 40.8 (1.05) 30.8 (0.90)
2004–2007 44.4 (1.04) 38.6 (0.96)
2008–2012 56.7 (1.43) 54.2 (1.37)
  1. eox life expectancy estimate (years), SE standard error, IDU injection drug use, ART antiretroviral therapy